淡江大學 |
2023-06-24 |
JCF: Joint Coarse and Fine-Grained Similarity Comparison for Plagiarism Detection Based on NLP
|
Chang, C. Y.;Jhang, S.-J.;Wu, S.-J.;Roy, D. S. |
淡江大學 |
2023-06 |
WLARS: Work Load Aware Recharge Scheduling Mechanism for Improving Surveillance Quality in Wireless Rechargeable Sensor Networks
|
Dande, B.;Chang, C. Y.;Wu, S.-J.;Roy, Diptendu Sinha |
淡江大學 |
2023-03 |
Determination of warranty length for one-shot devices with Rayleigh lifetime distribution
|
Wu, S.-J.;Huang, S.-R.;Wang, J.-H. |
臺大學術典藏 |
2022-08-23T02:35:03Z |
Polatuzumab vedotin�Vbased salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experience
|
Wang Y.-W.; Tsai X.C.-H.; Hou H.-A.; Tien F.-M.; Liu J.-H.; Chou W.-C.; Ko B.-S.; Chen Y.-W.; Lin C.-C.; Cheng C.-L.; Lo M.-Y.; Lin Y.-C.; Lu L.-C.; Wu S.-J.; SUNG-HSIN KUO; Hong R.-L.; Huang T.-C.; Yao M. |
臺大學術典藏 |
2022-05-11T07:47:51Z |
Clinical and prognostic implications of roundabout 4 (Robo4) in adult patients with acute myeloid leukemia
|
YIN-KAI CHEN; Hou H.-A.; Tang J.-L.; Jhuang J.-Y.; Lai Y.-J.; Lee M.-C.; Kuo Y.-Y.; Chou W.-C.; Liu C.-Y.; Lin C.-W.; Chuang S.-S.; Chen C.-Y.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Yao M.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Tsay W.; Chen Y.-C.; Tien H.-F. |
臺大學術典藏 |
2022-05-05T05:16:29Z |
Three single-nucleotide polymorphisms of the angiotensinogen gene and susceptibility to hypertension: Single locus genotype vs. haplotype analysis
|
Wu S.-J.; Chiang F.-T.; WEI J. CHEN; Liu P.-H.; Hsu K.-L.; Hwang J.-J.; Lai L.-P.; Lin J.-L.; Tseng C.-D.; Tseng Y.-Z. |
臺大學術典藏 |
2022-04-25T07:36:16Z |
Reduced incidence of interstitial pneumonitis after Allogeneic hematopoietic stem cell transplantation using a modified technique of total body irradiation
|
Chiang Y.; Tsai C.-H.; Kuo S.-H.; Liu C.-Y.; Yao M.; Li C.-C.; Huang S.-Y.; Ko B.-S.; Lin C.-T.; Hou H.-A.; Chou W.-C.; JIA-HAU LIU; Lin C.-C.; Wu S.-J.; Hsu S.-C.; Chen Y.-C.; Lin K.-H.; Lin D.-T.; Chou H.-T.; Lu M.-Y.; Yang Y.-L.; Chang H.-H.; Liu M.-C.; Liao X.-W.; Wu J.-K.; Chou S.-C.; Cheng C.-L.; Chen C.-Y.; Tsay W.; Tien H.-F.; Tang J.-L.; Chen Y.-H. |
臺大學術典藏 |
2022-04-25T07:36:14Z |
Clinically validated machine learning algorithm for detecting residual diseases with multicolor flow cytometry analysis in acute myeloid leukemia and myelodysplastic syndrome
|
Ko B.-S.; Wang Y.-F.; Li J.-L.; Li C.-C.; Weng P.-F.; Hsu S.-C.; Hou H.-A.; Huang H.-H.; Yao M.; Lin C.-T.; JIA-HAU LIU; Tsai C.-H.; Huang T.-C.; Wu S.-J.; Huang S.-Y.; Chou W.-C.; Tien H.-F.; Lee C.-C.; Tang J.-L. |
臺大學術典藏 |
2022-04-25T07:36:14Z |
Concomitant WT1 mutations predict poor prognosis in acute myeloid leukemia patients with double mutant CEBPA
|
Tien F.-M.; Hou H.-A.; Tang J.-L.; Kuo Y.-Y.; Chen C.-Y.; Tsai C.-H.; Yao M.; Lin C.-T.; Li C.-C.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; JIA-HAU LIU; Chou S.-C.; Tsay W.; Tseng M.-H.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Chou W.-C.; Tien H.-F. |
臺大學術典藏 |
2022-04-25T07:36:13Z |
Adoptive donor immunity protects against resolved hepatitis B virus reactivation after allogeneic haematopoietic stem cell transplantation in the world's largest retrospective cohort study
|
JIA-HAU LIU; Liao X.-W.; Chen C.-H.; Yao M.; Li C.-C.; Lin C.-T.; Tsai C.-H.; Chou W.-C.; Hou H.-A.; Huang S.-Y.; Wu S.-J.; Chen Y.-C.; Tien H.-F.; Tang J.-L.; Ko B.-S. |
臺大學術典藏 |
2022-04-25T07:36:12Z |
Distinct clinico-biological features in AML patients with low allelic ratio FLT3-ITD: role of allogeneic stem cell transplantation in first remission
|
Tien F.-M.; Tsai C.-H.; Huang S.-C.; JIA-HAU LIU; Chen C.-Y.; Kuo Y.-Y.; Chuang Y.-K.; Tseng M.-H.; Peng Y.-L.; Liu M.-C.; Liu C.-W.; Liao X.-W.; Lin L.-I.; Wu Y.-S.; Hou M.-F.; Wu S.-J.; Hsu S.-C.; Ko B.-S.; Chou W.-C.; Yao M.; Hou H.-A.; Tang J.-L.; Tien H.-F. |
臺大學術典藏 |
2022-04-25T07:36:11Z |
Polatuzumab vedotin�Vbased salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experience
|
Wang Y.-W.; Tsai X.C.-H.; Hou H.-A.; Tien F.-M.; JIA-HAU LIU; Chou W.-C.; Ko B.-S.; Chen Y.-W.; Lin C.-C.; Cheng C.-L.; Lo M.-Y.; Lin Y.-C.; Lu L.-C.; Wu S.-J.; Kuo S.-H.; Hong R.-L.; Huang T.-C.; Yao M. |
臺大學術典藏 |
2022-04-14T07:20:27Z |
Hyperleukocytosis is associated with distinct genetic alterations and is an independent poor-risk factor in de novo acute myeloid leukemia patients
|
FENG-MING TIEN; Hou H.-A.; Tsai C.-H.; Tang J.-L.; Chen C.-Y.; Kuo Y.-Y.; Li C.-C.; Lin C.-T.; Yao M.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Tsay W.; Tseng M.-H.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Chou W.-C.; Tien H.-F. |
臺大學術典藏 |
2022-04-14T07:20:27Z |
GATA2 zinc finger 1 mutations are associated with distinct clinico-biological features and outcomes different from GATA2 zinc finger 2 mutations in adult acute myeloid leukemia
|
FENG-MING TIEN; Hou H.-A.; Tsai C.-H.; Tang J.-L.; Chiu Y.-C.; Chen C.-Y.; Kuo Y.-Y.; Tseng M.-H.; Peng Y.-L.; Liu M.-C.; Liu C.-W.; Liao X.-W.; Lin L.-I.; Lin C.-T.; Wu S.-J.; Ko B.-S.; Hsu S.-C.; Huang S.-Y.; Yao M.; Chou W.-C.; Tien H.-F. |
臺大學術典藏 |
2022-04-14T07:20:26Z |
Concomitant WT1 mutations predict poor prognosis in acute myeloid leukemia patients with double mutant CEBPA
|
FENG-MING TIEN; Hou H.-A.; Tang J.-L.; Kuo Y.-Y.; Chen C.-Y.; Tsai C.-H.; Yao M.; Lin C.-T.; Li C.-C.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Liu J.-H.; Chou S.-C.; Tsay W.; Tseng M.-H.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Chou W.-C.; Tien H.-F. |
臺大學術典藏 |
2022-04-14T07:20:23Z |
ASXL1 mutation confers poor prognosis in primary myelofibrosis patients with low JAK2V617F allele burden but not in those with high allele burden
|
Wang Y.-H.; Lin C.-C.; Lee S.-H.; Tsai C.-H.; Wu S.-J.; Hou H.-A.; Huang T.-C.; Kuo Y.-Y.; Yao M.; Chang K.; Lin C.-W.; Lin Y.-C.; FENG-MING TIEN; Chou W.-C.; Tang J.-L.; Tien H.-F. |
臺大學術典藏 |
2022-04-14T07:20:22Z |
Polatuzumab vedotin�Vbased salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experience
|
Wang Y.-W.; Tsai X.C.-H.; Hou H.-A.; FENG-MING TIEN; Liu J.-H.; Chou W.-C.; Ko B.-S.; Chen Y.-W.; Lin C.-C.; Cheng C.-L.; Lo M.-Y.; Lin Y.-C.; Lu L.-C.; Wu S.-J.; Kuo S.-H.; Hong R.-L.; Huang T.-C.; Yao M. |
臺大學術典藏 |
2022-04-14T07:20:22Z |
Distinct clinico-biological features in AML patients with low allelic ratio FLT3-ITD: role of allogeneic stem cell transplantation in first remission
|
FENG-MING TIEN; Tsai C.-H.; Huang S.-C.; Liu J.-H.; Chen C.-Y.; Kuo Y.-Y.; Chuang Y.-K.; Tseng M.-H.; Peng Y.-L.; Liu M.-C.; Liu C.-W.; Liao X.-W.; Lin L.-I.; Wu Y.-S.; Hou M.-F.; Wu S.-J.; Hsu S.-C.; Ko B.-S.; Chou W.-C.; Yao M.; Hou H.-A.; Tang J.-L.; Tien H.-F. |
臺大學術典藏 |
2022-04-08T09:23:14Z |
EBV-positive Hodgkin lymphoma is associated with suppression of p21cip1/waf1and a worse prognosis
|
Liu T.-Y.; Wu S.-J.; Huang M.-H.; Lo F.-Y.; Tsai M.-H.; CHING-HWA TSAI; Hsu S.-M.; Lin C.-W. |
臺大學術典藏 |
2022-03-28T06:27:51Z |
Innate immunity and primary biliary cirrhosis: Activated invariant natural killer T cells exacerbate murine autoimmune cholangitis and fibrosis
|
Wu S.-J.; YAO-HSU YANG; Tsuneyama K.; Leung P.S.; Illarionov P.; Gershwin M.E.; Chuang Y.-H. |
臺大學術典藏 |
2022-02-23T02:12:34Z |
Primary effusion lymphoma in three patients with chronic hepatitis B infection
|
Wu S.-J.; Hung C.-C.; CHIEN-HUNG CHEN; Tien H.-F. |
臺大學術典藏 |
2022-02-23T02:12:23Z |
Adoptive donor immunity protects against resolved hepatitis B virus reactivation after allogeneic haematopoietic stem cell transplantation in the world's largest retrospective cohort study
|
Liu J.-H.; Liao X.-W.; CHIEN-HUNG CHEN; Yao M.; Li C.-C.; Lin C.-T.; Tsai C.-H.; Chou W.-C.; Hou H.-A.; Huang S.-Y.; Wu S.-J.; Chen Y.-C.; Tien H.-F.; Tang J.-L.; Ko B.-S. |
臺大學術典藏 |
2022-02-22T05:34:27Z |
Primary effusion lymphoma in three patients with chronic hepatitis B infection
|
Wu S.-J.; Hung C.-C.; CHIEN-HUNG CHEN; Tien H.-F. |
臺大學術典藏 |
2022-02-22T05:34:13Z |
Adoptive donor immunity protects against resolved hepatitis B virus reactivation after allogeneic haematopoietic stem cell transplantation in the world's largest retrospective cohort study
|
Liu J.-H.; Liao X.-W.; CHIEN-HUNG CHEN; Yao M.; Li C.-C.; Lin C.-T.; Tsai C.-H.; Chou W.-C.; Hou H.-A.; Huang S.-Y.; Wu S.-J.; Chen Y.-C.; Tien H.-F.; Tang J.-L.; Ko B.-S. |
臺大學術典藏 |
2022-02-07T07:49:00Z |
Polatuzumab vedotin�Vbased salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experience
|
Wang Y.-W.; Tsai X.C.-H.; Hou H.-A.; Tien F.-M.; Liu J.-H.; Chou W.-C.; Ko B.-S.; Chen Y.-W.; Lin C.-C.; Cheng C.-L.; Lo M.-Y.; Lin Y.-C.; Lu L.-C.; Wu S.-J.; SUNG-HSIN KUO; Hong R.-L.; Huang T.-C.; Yao M. |